株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

超崩壊剤の世界市場 - 製品別 (クロスポビドン、クロスカルメロースナトリウム、イオン交換樹脂、デンプングリコール酸ナトリウムなど)・剤型別・地域別 (北米、欧州、アジア太平洋地域など):市場分析・シェア・動向・規模・予測

Superdisntegrants Market, By Product (Crospovidone, Croscarmellose sodium, Ion Exchange Resin, Sodium Starch Glycolate, Others), by Dosage Form, by Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 796157
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
超崩壊剤の世界市場 - 製品別 (クロスポビドン、クロスカルメロースナトリウム、イオン交換樹脂、デンプングリコール酸ナトリウムなど)・剤型別・地域別 (北米、欧州、アジア太平洋地域など):市場分析・シェア・動向・規模・予測 Superdisntegrants Market, By Product (Crospovidone, Croscarmellose sodium, Ion Exchange Resin, Sodium Starch Glycolate, Others), by Dosage Form, by Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2019年02月25日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の超崩壊剤の市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、製品別・剤型別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 超崩壊剤市場:概要

第2章 エグゼクティブ・サマリー

第3章 超崩壊剤市場:主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 超崩壊剤市場:産業分析

  • ポーターのファイブフォース分析
  • 市場求心力の分析
  • 規制体制の分析

第5章 超崩壊剤の市場環境

  • 市場シェア分析

第6章 超崩壊剤市場:製品別

  • 概要
  • クロスポビドン
  • クロスカルメロースナトリウム
  • イオン交換樹脂
  • デンプングリコール酸ナトリウム
  • その他
    • 概要
    • 市場分析・予測、年間成長率 (金額ベース、通算12年間分)

第7章 超崩壊剤市場:剤型別

  • イントロダクション
  • 固形剤
  • 口腔内溶解フィルム

第8章 超崩壊剤市場:地域別

  • イントロダクション
  • 北米市場 (米国、カナダ)
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
    • 国別分析
  • 欧州市場 (フランス、ドイツなど)
  • アジア太平洋地域市場 (中国、インドなど)
  • 他の国々の市場 (RoW:ラテンアメリカ、中東・アフリカ)

第9章 主要ベンダーの分析

  • 概要
  • Ashland Global Holdings, Inc.
    • 企業概要
    • SWOT分析
    • 近年の主な動向
  • FMC Corporation
  • DFE Pharma
  • 日本曹達
  • Dow Pharma Solutions
  • BASF

第10章 アナリストの全方位的分析

第11章 付録

図表
x

List of Tables

  • Table 1: List of Acronyms
  • Table 2: Key Market Facts, 2014 - 2025
  • Table 3: Market Drivers: Impact Analysis
  • Table 4: Market Restraint: Impact Analysis
  • Table 5: Market Opportunity: Impact Analysis
  • Table 6: PEST Analysis
  • Table 7: Porter's Five Forces Analysis
  • Table 8: Company Market Share Analysis
  • Table 9: Global Superdisntegrants Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10: Superdisntegrants Market, by Product, 2014 - 2025 (USD Billion)
  • Table 11: Superdisntegrants Market, by Dosage Form, 2014 - 2025 (USD Billion)
  • Table 12: Superdisntegrants Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 13: North America Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 14: U.S. Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 15: Canada Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 16: Europe Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 17: France Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 18: Germany Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 19: Asia Pacific Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 20: China Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 21: India Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 22: Latin America Superdisntegrants Market, 2014 - 2025 (USD Billion)
  • Table 23: MEA Superdisntegrants Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Research Process Flow Chart
  • Figure 3: Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4: Regulatory Framework Analysis
  • Figure 5: Superdisntegrants Market, by Product, 2014 - 2025 (USD Billion)
  • Figure 6: Superdisntegrants Market, by Dosage Form, 2014 - 2025 (USD Billion)
  • Figure 7: Superdisntegrants Market, by Geography, 2014 - 2025 (USD Billion)
目次

REPORT HIGHLIGHT

The superdisintegrants market was valued at USD 380.2 million by 2017, growing with 8.1% CAGR during the forecast period, 2018-2025.

Market Dynamics

In contemporary oral medicines, disintegrants are added for aiding a quick dilution of the tablet in an aqueous environment and complementing a spontaneous release of the drug substance. A new genre of disintegrants has emerged in the market that is known as superdisintegrants. Natural products are biodegradable, chemically inert, and widely available. The good thing about it is you can customize it in several ways to dispense a system of drug delivery. Mucilages and natural gums are among the two widely used pharmaceutical superdisintegrants.

In modern oral medicines, these products are used in the form of emulsifiers, stabilizers, gelling agent, granulating agent, thickener, binder, and film former in the pharmaceutical industry. Over the years the demand for superdisintegrants made from natural sources has sky-rocketed because they are readily available and economically priced. Moreover, they are non-irritant and deliver soothing action.

Further, the natural product will receive a boost by virtue of being eco-friendly, and adaptable to several chemical modifications which make them compatible with different kinds of medicines. However, concerns over safety and quality are going to impede the market growth of superdisintegrants to large extent in the forecasted period.

Product Takeaway

The industry is segmented into natural, synthetic, and others. The synthetic products are further categorized into cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, calcium silicates, and ion exchange resins. In 2017, Crospovidone had the biggest revenue share. One of the reasons for such dominance in the market could be attributed to its higher crosslinking density. As a result, it swells rapidly in water without taking the form of a gel. It has a unique particle morphology featuring highly compressible materials.

Croscarmellose sodium is an FDA approved superdisintegrants that works on the principles of cross-linking paving the way for a much-improved bioavailability through superior drug dissolution. The use of this substance has been deemed safe by FDA when used in normal quantities.

Dosage Form Insights

The industry, in 2017, was dominated by solid dosage forms i.e. capsules and tablets. Superdisintegrants are one of the most important excipients of capsule and tablet formulation because they are capable of inducing breakups the moment it comes into contact with aqueous fluid. Capsules and tablets have quick dissolving dosage form duly recognized by FDA. The doses are listed in the catalog of approved drug products along with therapeutic equivalence evaluations that would be boosting the segment's growth. The number of disintegrates having usage in multifunctional tablet and capsule formulation is inclusive of starch, crospovidone, cellulose, and others. Mouth dissolving films segment will experience the highest growth during the forecasted period. Ability to rapidly disintegrate and dissolve in the oral cavity, accurate dosing, quick action, better patient compliance for the pediatric population are the factors propelling the growth of the segment.

Regional Takeaway

North America is the dominant region owing to the surging demand for generic drugs, better innovation in the manufacturing of this chemical product. It is anticipated that by virtue of increased outsourcing of excipients the Asia Pacific region will grow at the fastest CAGR along with manufacturing of the latest superdisintegrants, and incorporation of novel technologies.

The emergence of pharmaceutical giants in the region with humungous production capabilities and high consumption of excipients provides a befitting explanation for the large share of this region. Moreover, the ever-increasing demand for superior pharmaceutical products and generics will provide the necessary impetus for sustainable growth in the region.

Key Vendor Takeaways

Currently, the industry is fragmented in itself with the presence of numerous key vendors. The companies that dominate the global market are Ashland Global Holdings, Inc., FMC Corporation, DFE Pharma, Nippon Soda Co., Ltd., Dow Pharma Solutions, and BASFStrategic undertakings of these companies to increase their revenue share over the future period emphasizes on mergers, acquisition, and regional expansions.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

  • Crospovidone
  • Croscarmellose sodium
  • Ion Exchange Resin
  • Sodium Starch Glycolate
  • Others

MARKET, BY DOSAGE FORM

  • Solid Dosage Form
  • Mouth-dissolving Films

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENTS

1. SUPERDISNTEGRANTS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. SUPERDISNTEGRANTS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. SUPERDISNTEGRANTS INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. SUPERDISNTEGRANTS MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. SUPERDISNTEGRANTS MARKET - BY PRODUCT

  • 6.1. Overview
  • 6.2. Crospovidone
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Croscarmellose sodium
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. Ion Exchange Resin
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.5. Sodium Starch Glycolate
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.6. Others
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. SUPERDISNTEGRANTS MARKET- BY DOSAGE FORM

  • 7.1. Introduction
  • 7.2. Solid Dosage Form
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Mouth-dissolving Films
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. SUPERDISNTEGRANTS MARKET- BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.3. U.S.
    • 8.2.3.1. Overview
    • 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.4. Canada
    • 8.2.4.1. Overview
    • 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.3. France
    • 8.3.3.1. Overview
    • 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.4. Germany
    • 8.3.4.1. Overview
    • 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.5. Rest of Europe
    • 8.3.5.1. Overview
    • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.3. China
    • 8.4.3.1. Overview
    • 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.4. India
    • 8.4.4.1. Overview
    • 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.5. Rest of APAC
    • 8.4.5.1. Overview
    • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.5. Rest of the World
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.3. Latin America
    • 8.5.3.1. Overview
    • 8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.4. Middle East and Africa
    • 8.5.4.1. Overview
    • 8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

9. KEY VENDOR ANALYSIS

  • 9.1. Overview
  • 9.2. Ashland Global Holdings, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. SWOT Analysis
    • 9.2.3. Key Developments
  • 9.3. FMC Corporation
    • 9.3.1. Company Overview
    • 9.3.2. SWOT Analysis
    • 9.3.3. Key Developments
  • 9.4. DFE Pharma
    • 9.4.1. Company Overview
    • 9.4.2. SWOT Analysis
    • 9.4.3. Key Developments
  • 9.5. Nippon Soda Co. Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. SWOT Analysis
    • 9.5.3. Key Developments
  • 9.6. Dow Pharma Solutions
    • 9.6.1. Company Overview
    • 9.6.2. SWOT Analysis
    • 9.6.3. Key Developments
  • 9.7. BASF
    • 9.7.1. Company Overview
    • 9.7.2. SWOT Analysis
    • 9.7.3. Key Developments

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. Abbreviations
  • 11.3. Disclaimer
  • 11.4. Contact Us
Back to Top